NM_022114.4:c.43G>A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_022114.4(PRDM16):c.43G>A(p.Gly15Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,612,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022114.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000326 AC: 8AN: 245196Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 134156
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1459894Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 726286
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74342
ClinVar
Submissions by phenotype
not provided Uncertain:1
A variant of uncertain significance has been identified in the PRDM16 gene. The G15S variant has not been published as pathogenic or been reported as benign to our knowledge. This variant has been observed in 3/8490 (0.04%) alleles from individuals of East Asian ancestry, and 1/8960 (0.01%) alleles from individuals of African ancestry, in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The G15S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved across species and serine (S) is the wild-type residue at this position in multiple species. Finally, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at